Home › Funds › PERKINS CAPITAL MANAGEMENT INC › CSTL
PERKINS CAPITAL MANAGEMENT INC position in CSTL
CASTLE BIOSCIENCES INC · Health Care
PERKINS CAPITAL MANAGEMENT INC reported holding 49,315 shares of CSTL (CASTLE BIOSCIENCES INC) in its Q3 2026 13F filing — a position valued at US$1.8M, representing 1.25% of its reported portfolio and ranking #25 among its reported holdings. PERKINS CAPITAL MANAGEMENT INC has disclosed CSTL holdings in 13 of the last 13 reported quarters, going back to Q3 2023.
Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR
How PERKINS CAPITAL MANAGEMENT INC's CSTL position evolved
PERKINS CAPITAL MANAGEMENT INC first disclosed a stake in CSTL in Q3 2023 at 29,160 shares (US$493K). The position peaked in Q3 2026 at 49,315 shares, worth US$1.8M. Across 13 filings, PERKINS CAPITAL MANAGEMENT INC increased the stake 6 time(s), trimmed it 4 time(s) and left it unchanged 2 time(s). The most recent filing (Q3 2026) shows 49,315 shares valued at US$1.8M — an increase of 33,175 shares quarter over quarter.. Notable position changes include a 45% trim in Q1 2026 (shares fell 3% over the following quarter), a 206% increase in Q3 2026 (shares fell 5% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2023 | 29.16K | $493.00K | New |
| Q4 2023 | 32.14K | $694.00K | Add |
| Q1 2024 | 32.14K | $712.00K | Hold |
| Q2 2024 | 31.09K | $677.00K | Reduce |
| Q3 2024 | 32.64K | $930.89K | Add |
| Q4 2024 | 34.16K | $910.50K | Add |
| Q1 2025 | 33.97K | $679.98K | Reduce |
| Q2 2025 | 28.00K | $571.66K | Reduce |
| Q3 2025 | 28.14K | $640.86K | Add |
| Q4 2025 | 28.05K | $1.09M | Hold |
| Q1 2026 | 15.41K | $378.44K | Reduce |
| Q2 2026 | 16.14K | $384.94K | Add |
| Q3 2026 | 49.31K | $1.75M | Add |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About CSTL and 13F data
CSTL (CASTLE BIOSCIENCES INC) is a Health Care company. 29 other funds we track also report a position in CSTL — the largest reported positions include RTW INVESTMENTS, LP (US$66.3M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
More on PERKINS CAPITAL MANAGEMENT INC
FAQ
How long has PERKINS CAPITAL MANAGEMENT INC held CSTL?
PERKINS CAPITAL MANAGEMENT INC has disclosed CSTL holdings in 13 of the last 13 reported quarters, going back to Q3 2023.
What is PERKINS CAPITAL MANAGEMENT INC's current position in CSTL?
As of Q3 2026, PERKINS CAPITAL MANAGEMENT INC holds 49.31K shares of CSTL (CASTLE BIOSCIENCES INC), valued at $1.75M, representing 1.25% of its reported portfolio and ranking #25.
Has PERKINS CAPITAL MANAGEMENT INC been buying or selling CSTL?
In the latest 13F filing (Q3 2026), PERKINS CAPITAL MANAGEMENT INC increased its position in CSTL. The position peaked in Q3 2026 at 49.31K shares.
Which other funds hold CSTL?
Other major institutional holders of CSTL include RTW INVESTMENTS, LP, among 29 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.